NASDAQ · SABS
SAB Biotherapeutics, Inc.
$3.23+$0.03 (+0.94%)
SAB Biotherapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.28% below the high.
Loading market information…
AMEX · MLSS · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Milestone Scientific Inc.’s quoted price sits in the lower half of its reported 52-week range, 45.69% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Milestone Scientific Inc.’s next earnings report is currently expected on Nov 12, 2026, with estimated earnings per share of -$0.01. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Milestone Scientific Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Milestone Scientific Inc. is dedicated to the innovation, refinement, and global distribution of advanced diagnostic and therapeutic injection technologies and devices. These solutions cater to the medical, dental, and cosmetic industries, with a presence in the United States, China, and other international markets. The company's operations are divided into two main segments: Dental and Medical. Within its Dental division, key products include CompuDent and the STA Single Tooth Anesthesia System, both instrumental for delivering local anesthetics across all dental procedures. For broader applications, the firm offers CompuFlo, a sophisticated computer-controlled system capable of delivering drugs, anesthetics, and other medicaments comfortably and precisely, as well as aspirating bodily fluids or prior injections. Complementing this, a disposable injection handpiece provides precise tactile control during administration. In the Medical segment, Milestone Scientific introduces the CompuFlo Epidural, a computer-guided anesthesia system designed for a variety of medical applications. Additionally, their CompuMed system is utilized in numerous specialized procedures, including plastic surgery, hair restoration, colorectal surgery, podiatry, dermatology, and orthopedics, among others. Headquartered in Livingston, New Jersey, Milestone Scientific Inc. was established in 1989.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:33 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 15, 2025 | -$0.02-100.0% vs estimate | $2.23M-10.7% vs estimate |
|---|
| Q4 2024 | Mar 28, 2025 | -$0.03-155.1% vs estimate | $2.01M-24.12% vs estimate |
|---|
| Q3 2024 | Nov 14, 2024 | -$0.02-100.0% vs estimate | $2.51M-5.26% vs estimate |
|---|
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 1 contributors · Median target $1.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$3.23+$0.03 (+0.94%)
SAB Biotherapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.28% below the high.
$6.64+$0.24 (+3.75%)
Nutriband Inc.’s quoted price sits in the upper half of its reported 52-week range, 27.75% below the high.
$1.30+$0.04 (+3.17%)
Myomo, Inc.’s quoted price sits in the upper half of its reported 52-week range, 31.22% below the high.
$4.59+$0.25 (+5.76%)
Precision Optics Corporation, Inc.’s quoted price sits in the lower half of its reported 52-week range, 25.37% below the high.
$8.80+$0.38 (+4.51%)
Harvard Bioscience, Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.38% below the high.
$0.57+$0.02 (+2.79%)
MIRA Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 67.34% below the high.
$0.20-$0.04 (-16.55%)
IGC Pharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.81% below the high.
$0.58-$0.01 (-1.15%)
Retractable Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.67% below the high.
